Has Marjorie Ann Malbas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $221,902 in general payments to Marjorie Ann Malbas, MD across 791 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marjorie Ann Malbas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marjorie Ann Malbas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marjorie Ann Malbas, MD

Endocrinology, Diabetes & Metabolism · Rochester, MNNPI 1588977284

Payments from drug & device makers

$221,902in general payments, 2019–2025

Across 791 payments — averaging $280.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$177K
Ascendis Pharma Endocrinology Inc$36K
Tandem Diabetes Care, Inc.$1K
Novo Nordisk$1K
Radius Health, Inc.$902
AstraZeneca$857
plus $5K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	335	$177,091
Ascendis Pharma Endocrinology Inc	39	$35,617
Tandem Diabetes Care, Inc.	10	$1,486
Novo Nordisk	74	$1,280
Radius Health, Inc.	36	$902
AstraZeneca(2 entities)	43	$857
AbbVie	28	$513
Mannkind Corporation	27	$511
Lilly USA, LLC	35	$452
Kyowa Kirin, Inc.	3	$335
Abbott	19	$323
Amarin Pharma, Inc.	16	$265
Xeris Pharmaceuticals, Inc.	12	$249
Boehringer Ingelheim	14	$231
Dexcom, Inc.	10	$226
Johnson & Johnson	10	$148
Merck	8	$124
Bayer	6	$104
Sanofi	1	$103
Antares Pharma, Inc.	6	$102
Amneal Pharmaceuticals LLC	5	$98
Companion Medical, Inc.	10	$83
Insulet Corporation	5	$74
Sanofi-aventis U.S. LLC	4	$72
Eton Pharmaceuticals, Inc.	1	$67
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$65
Shire North American Group Inc	3	$62
Zealand Pharma US, Inc.	3	$58
Rhythm Pharmaceuticals, Inc.	2	$52
Vivus LLC	3	$42
Cequr Corporation	1	$35
Novartis	2	$35
Kowa Pharmaceuticals America, Inc.	2	$29
Pfizer	2	$26
Sun Pharmaceutical Industries Inc.	1	$22
BD	1	$20
Amryt Pharma Holdings Ltd	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Valeritas, Inc.	1	$16
IBSA Pharma Inc.	1	$15
Nalpropion Pharmaceuticals LLC	1	$14
Ascensia Diabetes Care US Inc.	1	$13
Esperion Therapeutics, Inc.	1	$13
Corcept Therapeutics	1	$13
Regeneron Healthcare Solutions, Inc.	1	$12
Ultragenyx Pharmaceutical Inc.	1	$12

How this compares

$221,902 in reported general payments places this provider in the 85th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.

See all endocrinology, diabetes & metabolism providers in Minnesota →

Medicare billing

Part B allowed, 2024

$104,036

Medicare patients

274

Services billed

2,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Rochester

Irina BancosRochester$4.8M
Yogish KudvaRochester$2.9M
Marius StanRochester$2.2M
John MorrisRochester$1.9M
Adrian VellaRochester$1.7M
Mabel RyderRochester$691K
Manpreet MundiRochester$388K
Bart ClarkeRochester$298K
Robert WermersRochester$188K
Diane DoneganRochester$175K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →